Topic
Piramal Pharma Solutions
Piramal Pharma Solutions announce $80 M investment plan to expand its Lexington, Kentucky facility
The expansion will add 24,000 square feet of manufacturing space Piramal Pharma Solutions, a part of Piramal Pharma, has announced…
Piramal Pharma Solutions launches ADCelerate
ADCelerate is a new, branded solution for antibody-drug conjugate drug development Piramal Pharma Solutions announced the launch of ADCelerate, a new, branded…
Piramal Pharma Solutions launches API plant at Aurora, Canada
The new plant, built as part of a CAD $30 million capital investment in the Aurora site, features more than…
Piramal Pharma Solutions appoints Herve Berdou as COO
Berdou will be based in the Northeastern US Piramal Pharma Solutions announced the appointment of Herve Berdou as Chief Operating…
Piramal acquires Hemmo Pharma for Rs775 crore
The acquisition is expected to add more than two hundred and fifty employees to PPS Piramal Pharma's Contract Development and…
Piramal Pharma Solutions in agreement with Plus Therapeutics
Plus Therapeutics' RNL-Liposome Intermediate Drug Product will be performed at Piramal Pharma Solutions' development and manufacturing site in Lexington, Kentucky…
Piramal Pharma Solutions announces sterile fill/finish programme with Theratechnologies
Drug product material will be used in a first-in-human clinical stud The Pharma Solutions business of Piramal Pharma, a leading…
Piramal Pharma Solutions invests around $32 m to expand Michigan facility
The expansion is planned to be ready for customers beginning summer 2022 Piramal Pharma Solutions is investing around $32 million…
Piramal Pharma Solutions Wins in Six Categories at the ‘CMO Leadership Awards 2018’
Piramal Pharma Solutions (PPS) is pleased to announce that it was recognized as a winner at the CMO Leadership Awards…